International Agency for Research on Cancer, World Health Organization. Cancer today. https://gco.iarc.fr/today/home. Accessed 25 Aug 2020.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. https://doi.org/10.3322/caac.21338.
Article
PubMed
Google Scholar
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.
Article
CAS
PubMed
Google Scholar
Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153–9. https://doi.org/10.1053/j.semdp.2016.12.011.
Article
PubMed
Google Scholar
Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019;156(2):477–91.e1.
Article
PubMed
Google Scholar
Reis AH, Vargas FR, Lemos B. Biomarkers of genome instability and cancer epigenetics. Tumour Biol. 2016;37(10):13029–38. https://doi.org/10.1007/s13277-016-5278-5.
Article
CAS
PubMed
Google Scholar
Kawano H, Saeki H, Kitao H, Tsuda Y, Otsu H, Ando K, et al. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma. Ann Surg Oncol. 2014;21(Suppl 4):S696–702.
Article
PubMed
Google Scholar
Ahuja N, Sharma AR, Baylin SB. Epigenetic therapeutics: a new weapon in the war against Cancer. Annu Rev Med. 2016;67(1):73–89. https://doi.org/10.1146/annurev-med-111314-035900.
Article
CAS
PubMed
PubMed Central
Google Scholar
Min HL, Kim J, Kim WH, Jang BG, Kim MA. Epigenetic silencing of the putative tumor suppressor gene GLDC (Glycine dehydrogenase) in gastric carcinoma. Anticancer Res. 2016;36(1):179–87.
CAS
PubMed
Google Scholar
Pan Y, Liu G, Zhou F, Su B, Li Y. DNA methylation profiles in cancer diagnosis and therapeutics. Clin Exp Med. 2018;18(1):1–14. https://doi.org/10.1007/s10238-017-0467-0.
Article
CAS
PubMed
Google Scholar
Han L, Xu G, Xu C, Liu B, Liu D. Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma. Oncol Lett. 2018;15(3):3552–7. https://doi.org/10.3892/ol.2018.7790.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li F, Li Q, Wu X. Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer. PLoS One. 2018;13(2):e0192494. https://doi.org/10.1371/journal.pone.0192494.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang H, Dong S, Feng J. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer. J Cell Biochem. 2019;120(6):10767–76. https://doi.org/10.1002/jcb.28368.
Article
CAS
PubMed
Google Scholar
Zhang M, Wang X, Chen X, Zhang Q, Hong J. Novel immune-related gene signature for risk stratification and prognosis of survival in lower-grade Glioma. Front Genet. 2020;11:363. https://doi.org/10.3389/fgene.2020.00363.
Article
CAS
PubMed
PubMed Central
Google Scholar
Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434–40. https://doi.org/10.1002/hep.510300629.
Article
CAS
PubMed
Google Scholar
Shim JH, Jun MJ, Han S, Lee YJ, Lee SG, Kim KM, et al. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg. 2015;261(5):939–46. https://doi.org/10.1097/SLA.0000000000000747.
Article
PubMed
Google Scholar
Zhang ZM, Zhang YM, Yao F, Yi P, Huang S, Liu JY, et al. Analysis on postoperative efficacy of radical hepatectomy for patients with non-HBV/HCV hepatocellular carcinoma. Asian Pac J Cancer Prev. 2015;16(8):3479–83. https://doi.org/10.7314/APJCP.2015.16.8.3479.
Article
PubMed
Google Scholar
Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947–55. https://doi.org/10.1097/SLA.0000000000000710.
Article
PubMed
Google Scholar
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009;10(3):223–32. https://doi.org/10.1016/S1470-2045(09)70003-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH, et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts. Blood. 2015;126(3):291–9. https://doi.org/10.1182/blood-2015-01-621664.
Article
CAS
PubMed
PubMed Central
Google Scholar
Döhner H, Dolnik A, Tang L, Seymour JF, Minden MD, Stone RM, et al. Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care. Leukemia. 2018;32(12):2546–57. https://doi.org/10.1038/s41375-018-0257-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, Ryan A, Kalsi JK, et al. A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. Br J Cancer. 2017;117(5):666–74. https://doi.org/10.1038/bjc.2017.199.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cooke AL, Morris J, Melchior JT, Street SE, Jerome WG, Huang R, et al. A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res. 2018;59(7):1244–55. https://doi.org/10.1194/jlr.M085332.
Article
CAS
PubMed
PubMed Central
Google Scholar
Subbaiah PV, Liu M, Witt TR. Impaired cholesterol esterification in the plasma in patients with breast cancer. Lipids. 1997;32(2):157–62. https://doi.org/10.1007/s11745-997-0020-5.
Article
CAS
PubMed
Google Scholar
Tahara D, Nakanishi T, Akazawa S, Yamaguchi Y, Yamamoto H, Akashi M, et al. Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease. Metabolism. 1993;42(1):19–23. https://doi.org/10.1016/0026-0495(93)90166-L.
Article
CAS
PubMed
Google Scholar
Carriere A, Ray H, Blenis J, Roux PP. The RSK factors of activating the Ras/MAPK signaling cascade. Front Biosci. 2008;13:4258–75. https://doi.org/10.2741/3003.
Article
CAS
PubMed
Google Scholar
Frödin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol. 1999;151(1–2):65–77. https://doi.org/10.1016/S0303-7207(99)00061-1.
Article
PubMed
Google Scholar
Anjum R, Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol. 2008;9(10):747–58. https://doi.org/10.1038/nrm2509.
Article
CAS
PubMed
Google Scholar
Fang YY, Ma FC, Gan XL, Luo WQ, He RQ, Xie HM, et al. Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study. Int J Clin Exp Pathol. 2018;11(3):1318–27.
PubMed
PubMed Central
Google Scholar
Fan L, Li P, Yin Z, Fu G, Liao DJ, Liu Y, et al. Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma. Br J Cancer. 2013;109(5):1137–46. https://doi.org/10.1038/bjc.2013.463.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dewdney SB, Rimel BJ, Thaker PH, Thompson DM Jr, Schmidt A, Huettner P, et al. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers. Clin Cancer Res. 2011;17(8):2120–9. https://doi.org/10.1158/1078-0432.CCR-10-2668.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rafiee M, Keramati MR, Ayatollahi H, Sadeghian MH, Barzegar M, Asgharzadeh A, et al. Down-regulation of ribosomal S6 kinase RPS6KA6 in acute myeloid leukemia patients. Cell J. 2016;18(2):159–64. https://doi.org/10.22074/cellj.2016.4310.
Article
PubMed
PubMed Central
Google Scholar
Arechavaleta-Velasco F, Zeferino-Toquero M, Estrada-Moscoso I, Imani-Razavi FS, Olivares A, Perez-Juarez CE, et al. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines. Med Oncol. 2016;33(2):11. https://doi.org/10.1007/s12032-015-0724-6.
Article
CAS
PubMed
Google Scholar
Thakur A, Sun Y, Bollig A, Wu J, Biliran H, Banerjee S, et al. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin Cancer Res. 2008;14(14):4427–36. https://doi.org/10.1158/1078-0432.CCR-08-0458.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez gene: gene-centered information at NCBI. Nucleic Acids Res. 2011;39(Database issue):D52–7. https://doi.org/10.1093/nar/gkq1237.
Article
CAS
PubMed
Google Scholar
Li GX, Ding ZY, Wang YW, Liu TT, Chen WX, Wu JJ, et al. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma. J Cell Physiol. 2019;234(7):11942–50. https://doi.org/10.1002/jcp.27882.
Article
CAS
PubMed
Google Scholar
Wang Y, Ruan Z, Yu S, Tian T, Liang X, Jing L, et al. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma. Aging. 2019;11(1):160–73. https://doi.org/10.18632/aging.101738.
Article
CAS
PubMed
PubMed Central
Google Scholar